Capitalizator.

Capitalize Yourself: Right Data. Real Growth.

Large Insider Purchases

Institutional-Scale SEC Form 4 Buy Signals

The Signal of $1M+ Conviction

When a corporate executive invests more than $1,000,000 of their own capital into company shares, it represents the highest level of conviction. These seven-figure purchases reflect management's belief in the company's future value.

Filing Date Trade Date Ticker Company Name Reporting Person Relationship Industry Type Price Qty Total, $ Owned After Change, %
2023-07-19 19:15 2023-07-17 CTR N/A Saba Capital Management, L.P. 10% owner Other BUY $32.13 45,499 $1,461,874 935,323 +5.1%
2023-07-19 19:06 2023-07-17 CEM N/A Saba Capital Management, L.P. 10% owner Other BUY $35.10 65,397 $2,295,664 1,525,427 +4.5%
2023-07-19 23:17 2023-07-17 THRX N/A GORDON CARL L Director, 10% owner Other BUY $3.05 479,932 $1,463,793 650,600 +281.2%
2023-07-19 22:14 2023-07-17 MTEM N/A BIOTECH TARGET N V 10% owner Other BUY $0.47 4,255,319 $2,000,000 15,447,322 +38.0%
2023-07-19 23:15 2023-07-17 THRX N/A ORBIMED ADVISORS LLC Director, 10% owner Other BUY $3.05 479,932 $1,463,793 650,600 +281.2%
2023-07-18 21:47 2023-07-14 GRIL Sadot Group Inc. AGGIA FZ LLC 10% owner Retail-Eating & Drinking Places BUY $3.12 8,855,452 $27,629,010 12,492,069 +243.5%
2023-07-18 16:00 2023-07-10 VBIV N/A GILLIS STEVEN Director Other BUY $1.65 609,090 $1,004,999 1,043,292 +140.3%
2023-07-18 03:00 2023-07-13 APGE Apogee Therapeutics Inc. Shah Nimish P Director Biological Products, (No Diagnostic Substances) BUY $17.00 1,750,000 $29,750,000 1,750,000 +100.0%
2023-07-18 03:00 2023-07-13 APGE Apogee Therapeutics Inc. Fairmount Funds Management LLC Director Biological Products, (No Diagnostic Substances) BUY $17.00 2,941,176 $49,999,992 892,529 +100.0%
2023-07-17 17:40 2023-07-12 NRGX PIMCO Dynamic Income Strategy Fund Saba Capital Management, L.P. 10% owner Other BUY $16.04 100,500 $1,612,000 5,318,001 +1.9%
2023-07-17 23:24 2023-07-13 ASAN Asana Inc. Moskovitz Dustin A. Director, Officer, 10% owner - President, CEO, & Chair Services-Prepackaged Software BUY $23.90 80,000 $1,912,000 40,312,803 +0.2%
2023-07-14 23:54 2023-07-12 N/A N/A J.P. Morgan Investment Management Inc. 10% owner, Other Other BUY $10.00 520,250 $5,202,500 530,250 +5,202.5%
2023-07-15 00:20 2023-07-12 CVGW CALAVO GROWERS INC COLE LECIL E Officer - Chief Executive Officer Agricultural Services BUY $30.34 75,000 $2,275,500 515,000 +17.0%
2023-07-14 00:15 2023-07-11 EVLO Evelo Biosciences Inc. Flagship Ventures Fund IV General Partner LLC 10% owner Pharmaceutical Preparations BUY $2.31 5,411,255 $12,499,999 3,931,685 +100.0%
2023-07-13 23:45 2023-07-12 BBXIA-B BBX Capital, Inc. LEVAN JARETT Director, Officer - CEO and President Retail-Food Stores BUY $11.20 121,698 $1,363,018 660,616 +22.6%
2023-07-12 23:11 2023-07-10 ASAN Asana Inc. Moskovitz Dustin A. Director, Officer, 10% owner - President, CEO, & Chair Services-Prepackaged Software BUY $21.72 160,000 $3,474,592 40,232,803 +0.4%
2023-07-13 02:22 2023-07-10 N/A N/A First Eagle Investment Management, LLC 10% owner Other BUY $25.00 1,052,000 $26,300,000 1,052,000 +100.0%
2023-07-10 23:17 2023-07-06 ASAN Asana Inc. Moskovitz Dustin A. Director, Officer, 10% owner - President, CEO, & Chair Services-Prepackaged Software BUY $21.34 160,000 $3,414,400 40,072,803 +0.4%
2023-07-07 23:30 2023-07-05 BDTX Black Diamond Therapeutics, Inc. RA CAPITAL MANAGEMENT, L.P. Director Biological Products, (No Diagnostic Substances) BUY $5.00 935,850 $4,679,250 3,213,828 +41.1%
2023-07-06 23:45 2023-07-05 BDTX Black Diamond Therapeutics, Inc. Behbahani Ali Director Biological Products, (No Diagnostic Substances) BUY $5.00 1,000,000 $5,000,000 4,448,757 +29.0%
2023-07-06 15:30 2023-07-05 PLCE Childrens Place, Inc. ELFERS JANE T Officer - President and CEO Retail-Family Clothing Stores BUY $23.70 43,000 $1,019,100 370,033 +13.1%
2023-07-05 18:29 2023-06-30 N/A N/A FSH SEED CAPITAL VEHICLE I LLC 10% owner Other BUY $27.99 183,739 $5,142,857 377,522 +94.8%
2023-07-05 18:29 2023-06-30 N/A N/A Franklin Square Holdings, L.P. 10% owner Other BUY $27.99 183,739 $5,142,857 377,522 +94.8%
2023-07-05 23:05 2023-06-30 MLTX MoonLake Immunotherapeutics Chen Bihua 10% owner Pharmaceutical Preparations BUY $50.00 800,000 $40,000,000 4,927,100 +19.4%
2023-07-05 18:42 2023-06-30 NRGX PIMCO Dynamic Income Strategy Fund Saba Capital Management, L.P. 10% owner Other BUY $15.85 128,249 $2,032,541 5,202,143 +2.5%
2023-07-05 18:31 2023-06-30 CEM N/A Saba Capital Management, L.P. 10% owner Other BUY $34.96 33,433 $1,168,861 1,445,999 +2.4%
2023-07-06 02:06 2022-10-26 BMN BlackRock 2037 Municipal Target Term Trust Hayes Peter Other Other BUY $25.00 40,000 $1,000,000 40,000 +100.0%
2023-07-05 18:31 2023-06-30 N/A N/A Adelman David J. 10% owner Other BUY $27.99 367,478 $10,285,714 377,522 +3,658.7%
2023-07-05 18:30 2023-06-30 N/A N/A Forman Michael C. Director, Officer, 10% owner - President & CEO Other BUY $27.99 367,478 $10,285,714 377,522 +3,658.7%
2023-07-05 23:15 2023-06-30 N/A N/A GENERAL ELECTRIC PENSION TRUST 10% owner Other BUY $995.44 35,160 $35,000,000 175,160 +25.1%
2023-07-06 00:16 2023-06-30 N/A N/A KKR Alternative Assets LLC 10% owner Other BUY $27.99 459,348 $12,857,143 943,806 +94.8%
2023-07-05 21:50 2023-07-01 N-A N/A VERONIS NICHOLAS Other Other BUY $32.40 650,000 $21,060,000 20,062 +100.0%
2023-07-03 22:38 2023-06-30 N-A N/A Manulife (Singapore) Pte. Ltd. 10% owner Other BUY $16.14 619,756 $10,000,011 3,244,055 +23.6%
2023-07-03 22:21 2023-06-30 N-A N/A Manufacturers Life Reinsurance Ltd 10% owner Other BUY $16.14 185,927 $3,000,003 11,396,182 +1.7%
2023-07-03 22:36 2023-06-30 BDTX Black Diamond Therapeutics, Inc. BIOTECH GROWTH N V 10% owner Biological Products, (No Diagnostic Substances) BUY $5.00 1,000,000 $5,000,000 8,117,839 +14.0%
2023-06-30 15:13 2023-06-30 MAX MediaAlpha, Inc. WHITE MOUNTAINS INSURANCE GROUP LTD Director, 10% owner Services-Business Services, NEC BUY $10.00 5,916,816 $59,168,160 22,856,814 +34.9%
2023-06-30 22:12 2023-06-28 RCUS Arcus Biosciences, Inc. GILEAD SCIENCES, INC. 10% owner Pharmaceutical Preparations BUY $19.26 1,010,000 $19,452,600 14,823,029 +7.3%
2023-06-30 23:17 2023-06-28 ASAN Asana Inc. Moskovitz Dustin A. Director, Officer, 10% owner - President, CEO, & Chair Services-Prepackaged Software BUY $22.57 160,000 $3,610,400 39,912,803 +0.4%
2023-07-01 00:34 2023-05-09 RXMD N/A Fernandez Charles M. Director, Officer - Chairman and CEO Other BUY $2.20 455,000 $1,001,000 758,517 +149.9%
2023-07-01 00:33 2023-05-09 RXMD N/A Barreto Rodney Director Other BUY $2.20 455,000 $1,001,000 773,517 +142.8%
2023-06-29 16:48 2023-06-27 N/A N/A FMR LLC 10% owner, Other Other BUY $25.23 346,723 $8,747,816 346,723 +100.0%
2023-06-30 02:05 2023-06-28 N-A N/A Employees' Retirement System of the State of Hawaii 10% owner Other BUY $14.82 637,652 $9,450,000 2,338,460 +37.5%
2023-06-30 00:17 2023-06-28 N/A N/A CAISSE DE DEPOT ET PLACEMENT DU QUEBEC 10% owner Other BUY $14.82 797,065 $11,812,500 2,944,514 +37.1%
2023-06-29 23:51 2023-06-27 ACET Adicet Bio, Inc. GORDON CARL L Director, 10% owner Pharmaceutical Preparations BUY $2.09 875,000 $1,828,750 748,054 +100.0%
2023-06-29 20:37 2023-06-27 BDTX Black Diamond Therapeutics, Inc. BIOTECH GROWTH N V 10% owner Biological Products, (No Diagnostic Substances) BUY $5.49 1,740,000 $9,555,036 7,117,839 +32.4%
2023-06-29 21:22 2023-06-28 CAPIX N/A CALAMOS JOHN P SR Officer - Global CIO Other BUY $10.03 747,756 $7,499,996 1,997,756 +59.8%
2023-06-30 01:03 2023-06-28 TRSSF TerrAscend Corp. JW Asset Management, LLC Director, 10% owner Agricultural Production-Crops BUY $1.50 800,002 $1,200,003 87,064,662 +0.9%
2023-06-29 23:46 2023-06-27 ACET Adicet Bio, Inc. ORBIMED ADVISORS LLC Director, 10% owner Pharmaceutical Preparations BUY $2.09 875,000 $1,828,750 748,054 +100.0%
2023-06-29 23:42 2023-06-27 PASG Passage BIO, Inc. ORBIMED ADVISORS LLC 10% owner Biological Products, (No Diagnostic Substances) BUY $0.84 1,192,577 $1,001,765 8,034,000 +17.4%
2023-06-30 00:21 2023-06-29 OKE ONEOK INC /NEW/ NORTON PIERCE Director, Officer - President & CEO Natural Gas Transmisison & Distribution BUY $60.96 24,607 $1,500,018 42,017 +141.3%
SHOW ENTRIES

Institutional Conviction in Form 4

Tracking these institutional-scale purchases allows you to follow the "smart money" when their conviction is highest. When an executive or a 10% beneficial owner commits a seven-figure sum to an open-market transaction, it bypasses the routine noise of stock-based compensation. These trades are often a precursor to major corporate developments or a signal that management views the current market valuation as significantly disconnected from the company’s internal growth trajectory. By monitoring these high-value entries, investors can align their portfolios with the capital of those who possess the most intimate understanding of a business's long-term health and potential.

Filtering the Market Noise

Our platform is designed to eliminate the noise and focus strictly on high-impact accumulation from directors and CEOs betting big on their company’s future. The SEC EDGAR database is frequently flooded with thousands of automated Form 4 filings, many of which involve small, technical, or pre-scheduled trades that offer little predictive value for the average investor. By applying a strict $1,000,000 minimum threshold, we isolate the transactions where insiders are taking substantial personal financial risk. This high-conviction filter serves as a powerful transparency tool, identifying the exact moments when corporate leadership moves away from passive ownership toward aggressive capital deployment.

UNDERSTANDING THE DATA

FILING DATE: The date and time when the transaction was reported to the SEC. This is when the public first receives the information.

TRADE DATE: The actual day the insider executed the purchase or sale in the market.

INDUSTRY: The specific market sector the company operates in. Useful for identifying broader institutional capital flows across sectors.

OWNED AFTER: The total number of shares held by the insider following the transaction. This highlights the insider's remaining conviction in the company.

CHANGE %: The percentage increase or decrease of the insider's total position. Large percentage changes often carry more weight than the dollar amount alone.

TRADE TYPES DEFINITIONS

BUY: An open market purchase. Typically indicates an insider's belief that the stock is undervalued or poised for growth.

SELL: An open market sale. While often used for diversification or liquidity, large or unexpected sales can be a warning signal.

OPT+S (OPTION EXERCISE & SALE): This occurs when an insider exercises their stock options and sells them immediately. Often part of a structured compensation plan.